Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD and Safety of ASP3652 in Healthy Men
NCT02034734Phase 1Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of asp3652 in chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS), sponsored by Astellas Pharma. Primary endpoints: Area under the plasma concentration-time curve in the dosing interval, Maximum observed plasma concentration and 2 more. Started Sep 2012; status: completed.
02
Drugs
asp3652
03
Conditions
chronic prostatitis (CP)chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT02034734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02034734.